Company
Reprieve Cardiovascular
| Industry | clinical-stage company pioneering intelligent decongestion management therapy for acute decompensated heart failure (ADHF) |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Reprieve Cardiovascular | Series B | 2025-08-27 |
| Reprieve Cardiovascular | Series A | 2024-02-20 |